www.kwongwah.com.my/?p=145970&from=singlemessage&i

New Post Public Reply Private Reply Replies (2) Message Board
malt66
638
www.kwongwah.com.my/?p=145970&from=singlemessage&isappinstalled=0

1 drop of blood cancer test 11 4 Psychiatric Zong positive precise medical world famous
NORTHERN MALAYSIA NEWS
26/05/201621:10
Reported: Chen Yani Photography: Zeng Guoquan

Professor Liu Zongzheng in 1967 received a doctorate in pathology, University of Toronto, Canada.
Professor Liu Zongzheng in 1967 received a doctorate in pathology, University of Toronto, Canada.

(Penang, 26 Jun) Malaysian-born scientist Dato 'Professor Liu Zongzheng found that "precision medicine" can detect whether a person will suffer from 11 cancers from a drop of blood in the next five years, and the results are well known in the world medical community. Not only the light of Malaysia, but also the light of Penang, Chung Ling and Han Jiang of the light!

Attend Han River and Chung Ling Secondary School

Professor Liu was born in 1937 in Perak, Malaysia. He is 79 years old. He is also an alumnus of Penang Chung Ling and Han Jiang Secondary School and Singapore Nanyang University. He has been in the United States last month in New York City related affirmation, and will be published in New York in June, "the use of RNA gene expression detection real-time, dynamic monitoring of the risk level of colorectal cancer."

He will also be back home recently published this great medical achievement. The colorectal sentinel is the world's first non-invasive blood test for colorectal cancer, measuring only 2.5 milliliters of blood to measure the blood in our blood. 7 The "colorectal outpost," which means the use of blood to detect the risk of colorectal cancer. Gene expression level to the risk of colorectal cancer with the possibility of quantitative analysis and evaluation.

Professor Liu 's discovery, the incidence of cancer for 3 consecutive years the country' s highest Penang more meaningful. With the development of medicine, cancer treatment has entered the era of "precision medicine", Professor Liu led the team can be measured from a drop of blood suffering from colorectal cancer, prostate cancer, breast cancer, liver cancer, child Cervical cancer, gastric cancer and other 11 kinds of cancer risk, and even detect 4 kinds of mental illness.

Currently, Dato 'Liu Zongzheng, a Malaysian Chinese scientist who has settled in Canada, graduated from Huadu Yaoyun Primary School in his early years. After graduating from junior high school in Yecheng Yucai Middle School, he was admitted to Hanjiang Middle School and transferred to Zhongling High School. Second class.

The so-called peripheral blood gene expression detection (abbreviation BGS), that is, in the concept of precision medicine, through non-invasive, convenient and mature peripheral blood sample collection, molecular "gene" level check, accurate detection of suffering from 11 Cancer and diseases including colorectal cancer, prostate cancer, liver cancer, lung cancer, nasopharyngeal cancer, stomach cancer, cervical cancer, breast cancer, osteoarthritis, ulcerative colitis, Crohn's disease, Mental illness, including depression, schizophrenia, dual personality and obsessive-compulsive disorder (Obsessive-compulsive disorder) the risk, so as to achieve the purpose of prevention and timely treatment.

Dato 'Professor Liu Zongzheng found that "precision medicine" can be detected from a drop of blood in a person in the next 5 years will suffer from 11 kinds of cancer and 4 kinds of mental illness, the results of the world famous medical profession.
Dato 'Professor Liu Zongzheng found that "precision medicine" can be detected from a drop of blood in a person in the next 5 years will suffer from 11 kinds of cancer and 4 kinds of mental illness, the results of the world famous medical profession.

Principle of the Sentry Set up a lab in Makati

US President Barack Obama announced in January last year, "precision medicine" program, proposed in the fiscal year 2016 to the program invested 215 million US dollars to promote the development of personalized medicine. In fact, as early as 30 years ago, Professor Liu Zongzheng has begun "outpost principle" in this area of ​​research, which is his life's efforts. Police post-swollen screening in 2006, received the Frost and Sullivan North American Technology Innovation Award. This is also in medical research, only in the Nobel Prize.

As the "outpost principle" is increasingly recognized in the United States, is widely used and community health management, disease prevention, disease prediction (including cardiovascular disease, mental illness, cancer, etc.), some experts predict that the future of this theory Most likely to obtain the Nobel Prize.

So far, Professor Liu has trained more than 60 world famous graduate students and doctors, and his students will carry forward the research results. In addition to Penang, the police post principle is also in Canada, the United States and Shanghai, China to promote in these four places with laboratories.

The objection principle has been questioned for over a decade

Professor Xue Kexiang, who followed Prof. Liu's research on precision medicine, said Professor Liu was the first researcher to advocate the principle of outpost. However, due to the objective factors, this argument was questioned and blocked for over 10 years. Until Professor Liu's research was successful, the medical profession began to accept his point of view.

Dr. Xue Kexiang Wang Pingsong (editor) and Chen Suhua explain this is the gene chip.
Dr. Xue Kexiang Wang Pingsong (editor) and Chen Suhua explain this is the gene chip.

Xue Kexiang to promote precision medicine

She is currently a medical director of the Oslo Medical Center in Penang and a clinical scientist. The medical center is located in the middle of the road. He returned to Malaysia five years ago. Professor Liu is a mentor of his Ph.D. Among the team of professors, Dr. Xue is the only one still staying in Malaysia to promote precision medicine, the other three have returned to Harvard Medical School.

According to Dr. Xue told the nearly 80-year-old Professor Liu is still active in the international academic exchange trip, to give lectures around the sharing of academic experience. As a result of Professor Liu's early years and Penang love, he has always been the heart of Penang, life's wish is to help Penang, Penang in the medical field step forward.

Dato 'Professor Liu Zongzheng graduated from Nanyang University in 1960, studied abroad in Canada in August 1962, received a master's degree in physiology from University of Toronto in 1964 and a Ph.D. in Pathology in 1967. He is a member of the Canadian Academy of Clinical Medicine, Life Sciences of the Royal College of Medicine, University of Toronto, Harvard University professor, an active advocate of transforming medicine. He has published more than 300 scientific papers in world-renowned academic journals such as Circulation, Nature, Science, and the Proceedings of the National Academy of Sciences. He has received 137 honorary professors from 137 universities. He was awarded the title of Senior Dato 'DMPN) in 2007 by Penang Head of State.

Liu Zongzheng 2 children also join the medical profession

In 2007 editor of the "Cardiovascular Genetics and Genomics for Cardiologist", the authority of the medical profession magazine "New England Journal of Medicine" This book is especially recommended molecular cardiovascular disease essential reference book.

His two sons are also engaged in the medical profession, for the surgeon, one is in the Boston hospital surgical department of high office, the other is an orthopedic surgeon. May be a lot of people do not know, that he is also a "plague fighter," the world famous doctor Wu Liande sun nephew generation.

Othel Medical Center is located in the middle of the road.
Othel Medical Center is located in the middle of the road.

Early diagnosis and early treatment of mental illness to help block the deterioration of the disease

According to Professor Liu Zongzheng in November last year, published in Shanghai, China "accurate detection - cancer and other malignancies preclinical prediction" speech, he pointed out that the importance of early detection of mental illness is early diagnosis and treatment may interrupt the brain Pathological changes in the process, blocking the progress of the disease, to avoid the occurrence of organic brain damage, improve the cure rate. A large number of studies at home and abroad show that early detection can help timely treatment, not only to eliminate the onset of psychiatric symptoms, to obtain good short-term effect, but also to improve long-term outcome. The longer the delay in treatment, the worse the treatment, the condition is easy to chronic, leading to mental disability.

In his view, the existing diagnosis of mental illness, mainly by observing the behavior of patients and communicate with patients to determine the patient's thinking, cognitive ability. Diagnosis is too dependent on the subjective judgment of doctors, the lack of objective diagnostic criteria, seriously hampered the early diagnosis of mental illness.

Southern Home Medical Inc. (SHOM) Stock Research Links

SHOM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Legal Heavyweight Joins Norris McLaughlin, Strengthens Team

Updated Category News Views 1

Veteran Attorney Joins the Allentown Office Buckle up, folks—there's a new legal heavyweight in town. David "Neil" Hittinger's move to Norris McLaughlin, P.A. is like adding an ace to an already stacked deck. Sure, it's not every day a law firm catches the eye, but when Hittinger, with his impressive portfolio, strides into the Allentown office, it makes waves. The firm...

Continue Reading
Meitav Tops 2025 Service Index with Stellar Growth

Updated Category News Views 4

Meitav’s Leap to The Summit Damn, it's a wild market when a pension fund provider snatches the crown. But here we are, looking at Meitav Provident Funds and Pension Ltd., standing proudly as Israel's top dog in the 2025 Service Index for pension funds. We're talking a jump from fourth to numero uno, folks, with a hefty score of 83 out of 100. And don't sleep on their...

Continue Reading
Food Emulsifiers Market Set for Significant Growth

Updated Category News Views 5

Market Potential: Scratching the Surface Who would have thought that a tiny ingredient like food emulsifiers would hold such massive sway in the food industry? Well, here we are, peering into a future where the global food emulsifiers market could skyrocket to a whopping USD 5.07 billion by 2035. That's right, these unsung heroes of the food world are shaking things up,...

Continue Reading
Brown Plus Ranks #8 Best Workplace for Women 2026

Updated Category News Views 9

Cracking the Top Ten: A Noteworthy Feat When it comes to hustling and bustling in the corporate world, Brown Plus managed to snag the spotlight by landing the #8 spot in the 'Best Place to Work for Women 2026.' It's a title they didn't just stumble upon. This recognition in the medium category by the Best Companies Group underscores the fact that Brown Plus is running its...

Continue Reading
FAA Greenlights Boeing’s 737-10: What’s at Stake?

Updated Category News Views 3

Breaking New Ground: Boeing 737-10 Certified Well, the folks at Boeing must be popping champagne, because the U.S. Federal Aviation Administration (FAA) just handed them the golden ticket: certification for the brand spankin' new Boeing 737-10. This ain't your average paper-pushing approval. We're talking nearly 1,000 test flights and what seems like a mountain of safety...

Continue Reading
Gildan Faces Heat: Channel Stuffing Allegations Arise

Updated Category News Views 3

Gildan's Stocks Take a Dive Amid Allegations Just when you thought the market swings were calming down, Gildan Activewear Inc. (NYSE: GIL) lands in hot water, sending investors scrambling. The spotlight's on them, thanks to some eye-catching accusations from Jehoshaphat Research. The word on the street is Gildan's been engaging in some questionable financial gymnastics...

Continue Reading
Tax Strategy Crucial: Sidnell & Webster of Lufkin Weigh In

Updated Category News Views 3

Breaking Down Tax Prep vs. Planning Ever wonder why some folks never break a sweat come tax season, while others scramble like their hair's on fire? It all boils down to understanding two very different animals: tax preparation and tax planning. CPA veterans Yvette Sidnell and Jennifer Webster over in Lufkin, Texas, have laid it out crystal clear in their article with...

Continue Reading
S?LACE Boats Unveils First Catamaran, the 41CT

Updated Category News Views 0

Setting a New Course with the 41CT Picture this: a company known for pushing the envelope does it again, but this time, they aren't just elbowing their way into the catamaran market—they're redefining it. S?LACE Boats has unveiled their all-new 41CT center console catamaran. Not just another addition, it's practically a game-changer for anyone passionate about offshore...

Continue Reading
AST SpaceMobile Faces Investor Turbulence Amid Concerns

Updated Category News Views 1

AST SpaceMobile's Unsteady Ground Let's dig into the wild ride AST SpaceMobile (NASDAQ: ASTS) has found itself on. These folks have been taking punches from every direction, from Wall Street's bean counters to hostile market winds. It all started when Scotiabank slapped them with a 'Sell' rating on January 6, 2026, pointing fingers at their faltering position against...

Continue Reading
Hyliion Partnership Woes: Investors Eye Legal Options

Updated Category News Views 4

Hyliion's Rocky Partnership Sparks Market Concern If you've got your cash tied up in Hyliion Holdings Corp. (NYSE: HYLN), you've probably got an eye twitch by now. Last June, a damning report from Pelican Way Research threw a wrench in Hyliion's plans with VFG Holdings, calling into question the whole commercial rationale of their newest partnership. Imagine staking $133...

Continue Reading

Top 5 Most Recently Viewed Articles

Editas Medicine Set to Present at the ESGCT Annual Congress

Updated Category News Views 182

Editas Medicine's Upcoming Presentation Highlights Editas Medicine, Inc. (NASDAQ: EDIT), a trailblazer in gene editing, is excited to announce that it will present at the renowned European Society of Gene and Cell Therapy (ESGCT) Congress. The congress is set to occur from October 7 to October 10, making this a significant occasion for the company and the field of gene...

Continue Reading
Innovative Solutions for Medical Devices: ICP DAS-BMP at COMPAMED

Updated Category News Views 193

ICP DAS-BMP Showcases Medical Innovations at COMPAMED ICP DAS-BMP, a prominent manufacturer from Taiwan, is gearing up for the prestigious COMPAMED event taking place in Germany. This event, which draws significant attention from the medical device industry, showcases advancements in medical-grade thermoplastic polyurethane (TPU) materials. Focus on Low-Migration and...

Continue Reading
Broadcom's Performance and ETF Options for Investors

Updated Category News Views 217

Broadcom's Recent Performance and Growth Potential Broadcom Inc. has made headlines recently with its remarkable performance in the tech sector. Following a solid earnings report for the second quarter, this semiconductor leader has seen its stock, designated as AVGO, score a notable jump of nearly 19% year-to-date. This surge has been particularly impressive, as the...

Continue Reading
InCarda Therapeutics Welcomes Dr. Myles Greenberg as CEO

Updated Category News Views 236

InCarda Therapeutics Welcomes Dr. Myles Greenberg as CEO InCarda Therapeutics, a clinical-stage biopharmaceutical firm dedicated to developing cutting-edge treatments for cardiac arrhythmias, has appointed Dr. Myles Greenberg, MD, MBA, as its new Chief Executive Officer. Dr. Greenberg is set to lead the company as they work on their flagship product, an orally inhaled...

Continue Reading
Jim Cramer's Insight: A Tipping Point for Nvidia's Stock

Updated Category News Views 148

Understanding Jim Cramer's Perspective on Nvidia CNBC’s Jim Cramer hinted at a potential turning point for NVIDIA Corp. (NASDAQ: NVDA) after the stock reached $127. This could signal a bottom for the semiconductor giant after its recent setbacks. Market Dynamics: What Cramer Noted Cramer’s Observations According to Cramer, the $127 mark could indicate a pivotal moment...

Continue Reading